News from all angles
(MedPage Today) -- Liver transplant patients who took a GLP-1 receptor agonist had a lower risk of death than those who weren't on a GLP-1 drug, according to a retrospective three-center cohort study…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network